cancer clinical trials in goshen, IN

Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer

Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Osteoporosis, Prostate Cancer

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Breast Cancer, Lung Cancer, Metastatic Cancer, Pain, Prostate Cancer

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Breast Cancer

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Indiana University Health Goshen Center For Cancer Care
Goshen, Indiana 46526

Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Breast Cancer

Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Colorectal Cancer, Metastatic Cancer

Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

Indiana University Health Goshen Center For Cancer Care
Goshen, Indiana 46526

Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer

Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Metastatic Cancer, Pancreatic Cancer

High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Lung Cancer, Radiation Toxicity

Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

Goshen Center for Cancer Care
Goshen, Indiana 46526

Purpura, Thrombocytopenic, Idiopathic, Autoimmune Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Autoimmune

Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Prostate Cancer

Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer

Goshen Cancer Center
Goshen, Indiana 46526

Pancreatic Cancer

Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Colorectal Cancer

Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma

Indiana University Health Goshen Center For Cancer Care
Goshen, Indiana 46526

Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma

Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Head and Neck Cancer, Xerostomia

Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer

IU Health Goshen Center for Cancer Care
Goshen, Indiana 46526

Breast Cancer

Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma

Center for Cancer Care at Goshen Hospital
Goshen, Indiana 46526

Mantle Cell Lymphoma

Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

Indiana University Health Goshen Center For Cancer Care
Goshen, Indiana 46526

Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer

Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma

Goshen Clinic
Goshen, Indiana 46526

Melanoma

Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Prostate Cancer, Sexual Dysfunction

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Prostate Cancer

Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Head and Neck Cancer

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery

Indiana University Health Goshen Center For Cancer Care
Goshen, Indiana 46526

Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer, Stage II Pancreatic Cancer

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

IU Health Goshen
Goshen, Indiana 46527

Renal Cell Carcinoma

Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Lung Cancer

Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer

IU Health Goshen Center for Cancer Care
Goshen, Indiana 46526

Prostate Cancer

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Center for Cancer Care @ Goshen Health Systems
Goshen, Indiana 46526

Chronic Lymphocytic Leukemia

Connect® MM- The Multiple Myeloma Disease Registry

Center for Cancer Care @ Goshen Health Systems
Goshen, Indiana 46526

Multiple Myeloma

Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL

Goshen Center for Cancer Care
Goshen, Indiana 46526

Non Hodgkin's Lymphoma, NHL, Aggressive NHL

Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma

IU Health Goshen Hospital
Goshen, Indiana 46527

Multiple Myeloma

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Head and Neck Cancer

Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Cognitive/Functional Effects, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific

Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Breast Cancer

Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

Center for Cancer Care at Goshen General Hospital
Goshen, Indiana 46526

Head and Neck Cancer, Precancerous Condition

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

Indiana University Health Goshen Center For Cancer Care
Goshen, Indiana 46526

Breast Cancer

Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors

IU Health Goshen Center for Cancer Care
Goshen, Indiana 46526

Advanced Renal Cell Carcinoma, Gastrointestinal Stromal Tumors, Pancreatic Neuroendocrine Tumors

Safety Study of Adenovirus Vector Engineered to Express hIL-12 (Human Interleukin 12) in Combination With Activator Ligand to Treat Melanoma

Indiana University Health Goshen Center For Cancer Care
Goshen, Indiana 46526

Unresectable Stage III or IV Melanoma

Efficacy & Safety of ODSH (2-0, 3-0 Desulfated Heparin) in Patients With Metastatic Pancreatic Cancer Treated With Gemcitabine & Abraxane

Indiana University Health, Goshen Center for Cancer Care
Goshen, Indiana 46526

Metastatic Pancreatic Cancer

A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.

Goshen Center for Cancer Care
Goshen, Indiana 46526

Metastatic Pancreatic Adenocarcinoma, Pancreatic Cancer, Metastatic Pancreatic Cancer

First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma

IU Health Goshen Hospital
Goshen, Indiana 46527

Urothelial Carcinoma

Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)

Goshen Center for Cancer Care
Goshen, Indiana 46526

Extensive-Stage Small Cell Lung Cancer

A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer.

Site Reference ID/Investigator# 65691
Goshen, Indiana 46526

Non-Small -Cell Lung Cancer

Dose Finding Study of Twice Weekly IMMU-130 in Metastatic Colorectal Cancer

IUHealth Goshen Center for Cancer Care
Goshen, Indiana 46526

Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer

Ph I Dose Escalation Study of Antibody-drug Conjugate IMMU-132 in Patients With Advanced Epithelial Cancers

IU Health Goshen Cancer Center
Goshen, Indiana 46526

Advanced Epithelial Cancers, Ovarian Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Gastric Cancer, Colorectal Cancer, Pancreatic Cancer, Hepatocellular Cancer

A Clinical Study Conducted in Multiple Centers Comparing Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Subjects With Brain Metastases From Non Small Cell Lung Cancer (NSCLC)

Site Reference ID/Investigator# 68494
Goshen, Indiana 46526

Brain Metastases From Non-small Cell Lung Cancer

OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone

IU Health Goshen Hospital
Goshen, Indiana 46527

Prostate Cancer, Metastatic Castrate-Resistant Prostate Cancer, PSA

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

Center for Cancer Care at Goshen Health System
Goshen, Indiana 46526

Breast Cancer

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

Center for Cancer Care at Goshen Health System
Goshen, Indiana 46526

Breast Cancer